Clinical trials of prepandemic flu vaccine developed by GlaxoSmithKline (GSK) PLC will start in Japan next month, the company’s Japan unit said Thursday.GSK K.K. plans to file an application with the health, Labor and Welfare Ministry possibly next year, for the vaccine’s adoption for the government’s stockpiling program.Currently, all prepandemic vaccines stockpiled by the government are domestically developed. GSK’s vaccine would be the first foreign-made one to be stockpiled in Japan if approved.The...

Info Petani -